Ovarian Cancer Recurrent
📧 Sign up to get email alerts when something new happens for Ovarian Cancer Recurrent.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression [Phase 2]
Phase 2 clinical trial investigating perioperative inhibition of beta-adrenergic and COX-2 signaling to reduce progression of ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors [Phase 2]
Phase 2 trial evaluating famitinib plus anti-PD1 therapy for advanced renal cell carcinoma, urothelial carcinoma, and gynecologic cancers su…
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Microtransplantation for Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for microtransplantation in recurrent ovarian cancer (Phase 1/Phase 2) with currently unknown status.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for adoptive T cell therapy in patients with recurrent ovarian cancer.